What are the validated rheumatoid arthritis joint activity scoring criteria (Disease Activity Score 28, Clinical Disease Activity Index, Simplified Disease Activity Index, RAPID3) and the standard radiographic scoring method (Sharp/van der Heijde)?

Rheumatoid Arthritis Joint Scoring Criteria

Disease Activity Scoring Systems

The American College of Rheumatology recommends six validated composite measures for assessing RA disease activity in clinical practice: DAS28 (ESR or CRP), CDAI, SDAI, RAPID-3, PAS, and PAS-II. 1

Recommended Measures by Category

Patient-Reported Measures (No Joint Counts Required)

These can be completed by patients in the waiting room within 3 minutes: 1

• RAPID-3 (Routine Assessment of Patient Index Data 3): Combines pain VAS (0-10), patient global assessment VAS (0-10), and Multidimensional HAQ (MDHAQ) functional assessment (10 items). Formula: (MDHAQ × 3.33 + pain VAS + PtGA VAS)/3. 1

  • Remission: ≤1.0
  • Low activity: >1.0 to 2.0
  • Moderate activity: >2.0 to 4.0
  • High activity: >4.0 to 10 1

• PAS (Patient Activity Scale): Uses original HAQ (41 items), pain VAS, and patient global VAS. Formula: (HAQ × 3.33 + pain VAS + PtGA VAS)/3. 1

• PAS-II: Uses HAQ-II (10 items), pain VAS, and patient global VAS. Same formula and cutoffs as PAS. 1

Provider + Patient Composite Measure

• CDAI (Clinical Disease Activity Index): Simple numerical addition without calculator needed: 28 swollen joint count + 28 tender joint count + provider global assessment (0-10) + patient global assessment (0-10). 1
  • Remission: ≤2.8
  • Low activity: >2.8 to 10.0
  • Moderate activity: >10.0 to 22.0
  • High activity: >22.0 1

Provider + Patient + Laboratory Measures

• SDAI (Simplified Disease Activity Index): Simple addition: 28 swollen joint count + 28 tender joint count + provider global assessment (0-10) + patient global assessment (0-10) + CRP (mg/dL). 1

  • Remission: ≤3.3 (ACR/EULAR recommended definition for clinical trials) 1
  • Low activity: >3.3 to ≤11.0
  • Moderate activity: >11.0 to ≤26
  • High activity: >26 1

• DAS28 (Disease Activity Score 28): Complex weighted formula requiring calculator. 1

  • DAS28-ESR: 0.56 × √(28TJC) + 0.28 × √(28SJC) + 0.70 × ln(ESR) + 0.014 × PtGA 1
  • DAS28-CRP: 0.56 × √(28TJC) + 0.28 × √(28SJC) + 0.36 × ln(CRP + 1) + 0.014 × PtGA + 0.96 1
  • Remission: <2.6
  • Low activity: ≥2.6 to <3.2
  • Moderate activity: ≥3.2 to ≤5.1
  • High activity: >5.1 1

Critical Caveats for DAS28 Use

The DAS28 has important limitations that can lead to misclassification of disease activity: 1

• ESR contributes 15% of the DAS28-ESR score, causing remission underestimation in high ESR states with few active joints, and overestimation in low ESR states despite significant swollen joints 1
• DAS28-CRP scores are generally lower than DAS28-ESR scores, potentially incorrectly estimating remission 1
• Biologic agents targeting specific inflammatory cytokines differentially affect ESR and CRP, potentially deflating composite scores disproportionately 1
• DAS28 remission criteria are less conservative than SDAI and CDAI, though treating to DAS28 ≤2.4 improves outcomes 1

Radiographic Scoring

For structural damage assessment, conventional radiographs of hands and feet should be the initial imaging technique, with the Sharp/van der Heijde method as the standard scoring system. 1

Imaging Recommendations for Joint Damage

• Initial assessment: Conventional radiography (CR) of hands and feet 1
• Early damage detection: Ultrasound and/or MRI should be considered when conventional radiographs show no damage, as they detect damage earlier (especially in early RA) 1
• Monitoring progression: Periodic evaluation of joint damage, usually by radiographs of hands and feet. MRI (and possibly ultrasound) is more responsive to change and can monitor disease progression 1

Prognostic Imaging Findings

• MRI bone edema: Strong independent predictor of subsequent radiographic progression in early RA; should be considered as a prognostic indicator 1
• Synovitis on MRI/ultrasound: Can predict further joint damage 1
• Inflammation in remission: MRI and ultrasound detect inflammation predicting subsequent joint damage even when clinical remission is present 1

Practical Selection Algorithm

Choose your measure based on clinical setting: 1

1. Busy clinic with time constraints: Use RAPID-3 (patient completes in waiting room, no joint counts needed) 1
2. Clinic with provider time for joint counts but no immediate lab access: Use CDAI (results available in real-time) 1
3. Academic/research settings with lab access: Use SDAI (most sensitive and specific for predicting treatment changes) 1
4. Clinical trials or treat-to-target protocols: Use DAS28 or SDAI (established treatment targets) 1

All six measures produce continuous indices with defined disease activity categories enabling systematic "treat-to-target" approaches. 1